Dear Reader,
President Trump’s State of the Union address is all over the news.
But what he DIDN’T talk about, is far more shocking than anything he did.
You see, President Trump made one major omission.
It concerns this secret plan to unlock $7.5 trillion in new wealth for American patriots...
That could help fast-track the retirements of millions.
If you want yours to be one of them…
You need to take a look at this immediately.
Because in my 30-years-plus in the markets…
I’ve never seen anything with as much jaw-dropping profit potential as this secret $7.5 trillion wealth plan.
This isn't being covered on CNBC, or Fox Business.
And – inexplicably – President Trump stayed silent on it at the State of the Union.
But it's the most shocking move of Trump's second term by far — and it's not even close.
It could have enormous implications for your wealth, your retirement, and your future.
So get up to speed on this fast-moving situation now – before it’s too late.
Before this secret $7.5 trillion wealth plan is all over the news.
Click here now for the full story.
To Your Profits,
Adam O'Dell
Chief Investment Strategist, Money & Markets
Tempus AI Sold Off After a Beat—But the Rebound Case Is Building
Written by Thomas Hughes. Date Posted: 2/25/2026.
Key Points
- Tempus AI is framed as deeply discounted versus analyst targets, with improving margins and guidance supporting a rebound setup.
- The quarter showed strong reported growth and durable retention, with narrowing losses and an improving profitability trajectory.
- Analyst sentiment and institutional buying are portrayed as supportive, while debt and short interest remain the main risks.
- Special Report: [Sponsorship-Ad-6-Format3]
Tempus AI (NASDAQ: TEM) looks like an attractive buy for tech traders. The company is a leading provider of AI-enabled services and infrastructure for healthcare, and the stock appears positioned for a robust rebound. Trading near 52-week lows in late February, shares are more than 45% below analysts' consensus price targets, leaving room for upside as positive catalysts emerge.
Drivers for a rebound include outperformance, better-than-expected guidance, and internal metrics showing not only rising client counts but also an enviable penetration rate.
Have $500? Invest in Elon's AI Masterplan (Ad)
What if you could claim a stake in what's set to be the biggest IPO ever… starting with just $500?
Everyone is talking about Elon Musk's SpaceX IPO.
The key takeaway for investors is that Tempus looks poised to inflect to profitability before year-end — a catalyst that could help lift the stock back toward, and potentially above, prior record levels. For more context, see our deeper discussion on what could push the market higher here.
Tempus AI Delivers Beat-and-Raise Quarter: Shares Fell
Tempus reported a strong quarter, with revenue growing at an impressive ~83% year-over-year rate. Revenue outpaced MarketBeat's reported consensus by roughly 120 basis points, led by a 121% gain in diagnostics, a 56% increase in MRD, and a 25% rise in Data & Applications. Much of the overall growth reflects acquisitions; on an organic basis, revenue rose about 33.5% — still a robust result. Remaining contract value sits above $1.1 billion, and net retention exceeds 125%.
Margin trends were encouraging as well. Losses narrowed, gross profit rose 94.7%, and adjusted EBITDA turned positive year over year, a meaningful improvement from the prior quarter. Adjusted results showed a small per-share loss but were materially better than consensus expectations, and management backed the quarter with constructive guidance.
Guidance gives investors two reasons to be optimistic. Management forecasted full-year 2026 revenue of $1.59 billion — roughly 65 basis points above consensus — and characterized guidance as conservative, implying potential upside if execution continues. That combination of beat-and-raise dynamics and cautious guidance increases the likelihood of upside in coming quarters.
Analysts Reaffirm Bullish Outlook for Tempus AI
Analysts largely held their views after the release, indicating results were broadly in line with expectations. The two early revisions tracked within the first 12 hours — from BTIG and Morgan Stanley — reaffirmed Buy and Overweight ratings, underscoring a generally bullish bias in the data.
Eight of the 14 ratings MarketBeat tracks are Buy or better, and the consensus is a Moderate Buy. Price targets remain constructive: although BTIG trimmed its target, the new $90 level still sits above consensus, and Morgan Stanley maintained a higher target that implies roughly 75% upside from current levels.
Institutional trends are also supportive. MarketBeat data show institutions own a relatively modest 25% stake but have been net buyers since the IPO. Q1 2026 activity was a record, with institutions purchasing more than $500 million in shares — about 5% of market cap — and buying roughly $3 for every $1 sold. That institutional accumulation provides a solid support base and reduces the likelihood of a deep, sustained sell-off. Critical technical support sits near $50 and could act as a launch pad if shares test that level.
Tempus Hits Bottom in Early 2026 Despite Risks
Risks include elevated debt and a meaningful short interest. Leverage is relatively high, but if the company hits its profitability inflection, that concern should diminish. With roughly 12% of the float sold short and an institutional tailwind, a short-covering dynamic could further amplify gains if the company executes.
Technically, the stock looks close to a bottom. Momentum indicators show oversold conditions and waning bearish momentum, setting the stage for a bullish swing. The timing and magnitude of any rally depend on catalysts that could arrive later in the year — expanding partnerships, a deepening client base, regulatory milestones, and new AI-enabled product launches are among the most likely triggers.
IonQ in Rebound Mode: Buy the Thesis, Respect the Risk
Written by Thomas Hughes. Date Posted: 3/3/2026.
Key Points
- IonQ's fiscal Q4 results beat expectations, but the stock's path forward depends on more than just one strong quarter.
- A major acquisition and surging government-adjacent demand could reshape the company's trajectory—if execution follows through.
- Institutional buying and elevated short interest are setting up a potential technical catalyst, though analysts aren't fully on board yet.
- Special Report: [Sponsorship-Ad-6-Format3]
IonQ’s (NYSE: IONQ) Q4 2025 earnings report may not yet signal a full shift in the quantum narrative. What it does show is demand for its services and execution of its strategy, putting the company on track to potentially dominate the industry. Management has refocused on the chips that drive quantum, a full-stack approach, and a unified platform for users. Critical takeaways include strong revenue and guidance, and a potential stock rebound that could add as much as 80% to 100% to the share price under the right conditions.
There are risks. The underlying technology generates revenue but remains in early stages. The company is not yet profitable, burns cash, and may need to dilute shares in the coming years. A 2025 share offering left IonQ well-capitalized, but it also increased shares outstanding by roughly 70% year over year, meaning equity gains could prove temporary. Much of the capital is earmarked for technology investment, expansion, and acquisitions, but continued operational losses could deplete the balance quickly.
Silver $309? (Ad)
Silver: 20% + 68%
Tim Plaehn just found a Silver ETF that delivers monthly income (up to 20% in annual distributions) plus share appreciation (68% in 5 months). The precious metal has become one of the best investments for growth AND income right now.
The acquisition pipeline includes SkyWater Technologies. Valued at $1.8 billion in cash and stock, the deal adds domestic foundry and development capabilities, giving IonQ greater control over its supply chain. SkyWater also brings existing customers, revenue, and profit-generation potential that could accelerate IonQ's timeline.
Analysts Respond Favorably: Limit IonQ Upside in 2025
The analysts’ response to the Q4 results is broadly bullish, with many citing substantial revenue outperformance, a growing backlog, and a strong guide. However, analysts largely did not raise price targets. MarketBeat tracked several estimate revisions in the first week after the release; most were reductions or new targets that landed at the low end of ranges. That activity can limit near-term upside, potentially capping gains at consensus or below, though the stock still has rebound potential of roughly 20% to 50% under favorable conditions.
Institutional and short-selling data suggest the potential for a short-covering rally or squeeze. The short interest, while below its peak, rose sequentially to about 25%—near long-term highs. That is a material headwind and could cap gains, but institutions offer an offset. Institutional investors own more than 40% of the shares and have been net buyers over the last several quarters.
MarketBeat data show the institutions are buying at a pace of more than $3 for every $1 sold, with buying and total activity ramping to record levels in early Q1 2026. This provides a solid support base: buying is broad-based across institutional groupings—not just index funds—and creates a tailwind for price action during a rebound. Institutional accumulation aligns with a technical price floor and the early-2026 bounce, with volume rising as prices advanced.
Long Path to Profits Raises Risks for Investors
The Q4 results were solid, and analysts are raising their estimates. Forecasts improved both near term and long term, but profitability remains a major hurdle. IonQ is expected to improve leverage over time, yet meaningful profits are not anticipated until well into the next decade. That long timeline leaves the stock exposed to volatility, execution risk, and competitive disruption. The company must execute cleanly; any delays or setbacks will be reflected in share price action.
Disruption could come from a pure-play competitor, but it is more likely to come from a deep-pocketed tech blue chip. For example, NVIDIA (NASDAQ: NVDA), which collaborates with IonQ on integration, has the cash resources to acquire IonQ multiple times over while still funding its core strategies, including investments that integrate quantum with classical computing.
Other Magnificent Seven names such as Alphabet (NASDAQ: GOOGL) and Microsoft (NASDAQ: MSFT) are also investing heavily in quantum. Alphabet is often viewed as the biggest threat; its Willow chip, released in late 2024, represents a meaningful step toward error reduction at scale and fault-tolerant systems.
This email message is a paid sponsorship for Banyan Hill Publishing, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you would like to unsubscribe from receiving offers for Strategic Fortunes, please click here.
If you have questions about your account, please feel free to contact MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl., Sixth Floor, Sioux Falls, South Dakota 57103. United States of America..
No comments:
Post a Comment